Clinical Trials Directory

Trials / Conditions / Metastatic Leiomyosarcoma

Metastatic Leiomyosarcoma

10 registered clinical trials studyying Metastatic Leiomyosarcoma — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingTesting the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) fo
NCT06498648
National Cancer Institute (NCI)Phase 1 / Phase 2
RecruitingXL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma
NCT06571734
Northwestern UniversityPhase 2
RecruitingTesting Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposert
NCT05711615
National Cancer Institute (NCI)Phase 1
WithdrawnNiraparib for the Treatment of Leiomyosarcoma
NCT05174455
David Liebner, MDPhase 2
Active Not RecruitingCabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tis
NCT04200443
City of Hope Medical CenterPhase 2
TerminatedItacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas
NCT03670069
Fred Hutchinson Cancer CenterPhase 1
TerminatedAvelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot
NCT03074318
Fred Hutchinson Cancer CenterPhase 1 / Phase 2
TerminatedSapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma
NCT02601209
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedSARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma
NCT02303262
Sarcoma Alliance for Research through CollaborationPhase 2
CompletedNivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma
NCT02428192
National Cancer Institute (NCI)Phase 2